Home > Offer to Sell > Intermediates > Pharmaceutical intermediates > Sunitinib malate CAS:341031-54-7
Sunitinib malate CAS:341031-54-7
Inquiry
| Post Date: | Jun 26,2015 |
| Expiry Date: | Dec 23,2015 |
| Detailed Description: |
Cas No. :341031-54-7
Quantity: 1000Kilograms Specs:Pharmacuetical raw materials intermediate ste Price:1 USD FCL Payment Method: Bank transfer, Western Union, Money Gram, Ban Here at Hubei Yuancheng Saichuang Technology Co.Ltd .we are one of the worlds leading manufactures of Anabolic Steroids and Ancillary pharmaceuticals for over 15 years. Specializing in "safety, efficiency, Security" service .Get the service and products your desire here. please contact me through c03 at yccreate.com Sunitinib malate Chinese alias:N- (2- (two ethyl amino) ethyl) -5- ((Z) - (5- -1,2- two -2- fluoride hydrogen oxygen generation -3H- indole -3- subunit) methyl) -2,4- two methyl -1H- pyrrole -3- formamide (2S) - hydroxy acid salt; sunitinib malate; sunitinib malate English name:N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate CAS:341031-54-7 The molecular formula:C22H27FN4O2.C4H6O5 Molecular weight:532.566 Appearance:Red powder Melting point:189℃～191℃ Assay:99% Packing:1kg aluminum foil bag or packaged according to customer requirements Use:Sunitinib malate by preventing cancer cells of blood and nutrients needed for growth play a role in the treatment. Clinical trials show that the medicine, can delay the gastrointestinal stromal tumor growth speed, and can reduce the size of renal cell cancer. Sunitinib malate is the first to selectively target multiple tyrosine kinase receptor model targeting drugs, combined with the suspension to the anti angiogenic blood supply of tumor cells and tumor directly attack the tumor cell two mechanisms. It represents a new round of the advent of targeted therapies, which can directly attack the tumor toxicity, nor conventional chemotherapy. Min. Order:10/Gram Supply Ability:mass stock More information,lps contact: c03@yccreate.com |
| CAS Registry Number: | 341031-54-7 |
| Synonyms: | ;SUNITINIB MALEATE;1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4- dimethyl-, (2S)-hydroxybutanedioate (1:1);Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2- (diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H- indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3- carboxamide (1:1);N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate;(2S)-2-hydroxybutanedioic acid - N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);2-hydroxypentanedioic acid - N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-(5-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrole-3-carboxamide (1:1);Sunitinib Mablate; |
| Molecular Formula: | C28H38N4O7 |
| Molecular Weight: | 542.62392 |
| Molecular Structure: | 
|
| Company: | wuhan technology development co.,ltd [ China ] |
| Contact: | gloriacui |
| Tel: | 027-50756026 |
| Fax: | 86-68886696874 |
| Email: | ycgc913@yccreate.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
